UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions

CONCLUSION: An association was identified between patients with chronic pain prescribed CBMPs and improvements in pain-specific and general HRQoL outcomes. Most adverse events were mild to moderate in severity, indicating CBMPs were well tolerated. Inherent limitations of study design limit its overall applicability.PMID:34937477 | DOI:10.1080/17512433.2022.2017771

Source: Pharmacological Reviews - December 23, 2021 Category: Drugs & Pharmacology Authors: Michael Harris Simon Erridge Mehmet Ergisi Devaki Nimalan Michal Kawka Oliver Salazar Rayyan Ali Katerina Loupasaki Carl Holvey Ross Coomber Azfer Usmani Mohammed Sajad James J Rucker Michael Platt Mikael H Sodergren Source Type: research